<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Tarbiat Modares University</PublisherName>
				<JournalTitle>Pathobiology Research</JournalTitle>
				<Issn>2538-3000</Issn>
				<Volume>29</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2026</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Status of serum antibodies against Mycobacterium tuberculosis among sulfur mustard-poisoned Iranian veterans three decades after exposure</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">28740</ELocationID>
			
<ELocationID EIdType="doi">10.48311/mjms.2026.120323.82624</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>KOBRA</FirstName>
					<LastName>SHIRANI</LastName>
<Affiliation>Unit 6.No 1,North golestan
Mahestan shahrak gharb</Affiliation>

</Author>
<Author>
					<FirstName>Mahmood</FirstName>
					<LastName>Sadeghi</LastName>
<Affiliation>Medical Toxicology and Drug Abuse Research Center, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Ghassemi Toussi</LastName>
<Affiliation>Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences,</Affiliation>

</Author>
<Author>
					<FirstName>Behzad</FirstName>
					<LastName>Bahadori</LastName>
<Affiliation>Imam Reza  Hospital, Mashhad University of Medical Sciences, Mashhad, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Bamdad</FirstName>
					<LastName>Riahi</LastName>
<Affiliation>Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences,</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2026</Year>
					<Month>05</Month>
					<Day>09</Day>
				</PubDate>
			</History>
		<Abstract>Background: Sulfur mustard (SM)-exposed veterans suffer from chronic respiratory complications. Many receive immunosuppressive therapy to alleviate pulmonary inflammation, which may create a favorable environment for opportunistic pathogens such as Mycobacterium tuberculosis (TB). Timely diagnosis and treatment of TB could improve their respiratory status. This study aimed to assess serum levels of specific anti-TB antibodies (IgM, IgG, IgA) as a screening tool to evaluate TB status in this population.&lt;br&gt;Methods: Serum anti-TB antibody levels were measured using commercial ELISA kits (Alpha Diagnostic, USA) in 35 male Iranian veterans with at least 25% disability due to SM poisoning three decades earlier.&lt;br&gt;Results: Titers of all anti-TB antibody classes (IgM, IgG, IgA) were below the cut-off value (&lt;8 U/mL) for all veterans, indicating negative results. No borderline (8–12 U/mL) or positive (&gt;12 U/mL) results were observed.&lt;br&gt;Conclusion: The universally low antibody levels may reflect SM induced dysfunction of both innate and adaptive immunity. Alternatively, the results could indicate the absence of active TB and suggest that revaccination against TB might be considered for these veterans by their physicians.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">MycobacterMycobacterium tuberculosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sulfur mustardium tuberculosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anti TB antibodies</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Veterans</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sulfur mustard</Param>
			</Object>
		</ObjectList>
</Article>
</ArticleSet>
